TickerFactsScreenerDevelopers

Vanda Pharmaceuticals Inc. (VNDA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$35.95M2010: $8.84M2011: -$10.71M2012: -$29.18M2013: -$21.20M2014: $20.06M2015: -$40.19M2016: -$18.57M2017: -$16.90M2018: $21.74M2019: $22.81M2020: $27.24M2021: $42.16M2022: $6.33M2023: -$13.95M2024: -$40.66M2025: -$151.17M-$151.17M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$151.17M-271.8%
2024-$40.66M-191.4%
2023-$13.95M-320.4%
2022$6.33M-85.0%
2021$42.16M+54.8%
2020$27.24M+19.4%
2019$22.81M+4.9%
2018$21.74M+228.6%
2017-$16.90M+9.0%
2016-$18.57M+53.8%
2015-$40.19M-300.3%
2014$20.06M+194.6%
2013-$21.20M+27.3%
2012-$29.18M-172.5%
2011-$10.71M-221.1%
2010$8.84M+124.6%
2009-$35.95M—